This article was generated by Benzinga's automated content engine and reviewed by an editor.

ProPhase Labs, Inc., a company specializing in pharmaceutical preparations with a current market capitalization of $8.16 million, has announced an executive shift with the departure of its current ...

专注于制药业务、目前市值816万美元的ProPhase Labs, Inc.宣布进行高管层变动，现任首席运营官 (COO) Jed Latkin即将离职，Stuart Hollenshead将接任新COO一职。此次人事变动紧随Pharmaloz Manufacturing, ...

Tivic Health Systems, Inc. TIVC rose 42% to $0.9937 in pre-market trading. Tivic Health Systems shares jumped 198% on ...

北京时间2025年02月12日03时33分，恩佐生化（ENZ.us）股票出现异动，股价快速下跌5.56%。截至发稿，该股报0.510美元/股，成交量26.0936万股， 换手率 0.50%，振幅8.98%。

北京时间2025年02月12日01时11分，丹纳赫（DHR.us）股票出现波动，股价大幅下跌1.73%。截至发稿，该股报199.98美元/股，成交量253.667万股， 换手率 0.35%，振幅1.46%。

ProPhase Labs, Inc. Transaction Eliminates More Than $20 Million in Debt, and Other Financial Obligations, Provides $2 million in Cash and Significantly Enhances the Company’s Balance Sheet and ...

Stock analysts at StockNews.com initiated coverage on shares of ProPhase Labs (NASDAQ:PRPH – Get Free Report) in a research ...

In a challenging year for ProPhase Labs, now valued at just $10 million in market cap, the company's stock has plummeted to a 52-week low, touching down at $0.41. This significant downturn reflects a ...